[HTML][HTML] Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons

…, A Mba-Jonas, SW Martin… - … England Journal of …, 2021 - Mass Medical Soc
Background Many pregnant persons in the United States are receiving messenger RNA (mRNA)
coronavirus disease 2019 (Covid-19) vaccines, but data are limited on their safety in …

Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis

CG Grijalva, JP Nuorti, PG Arbogast, SW Martin… - The Lancet, 2007 - thelancet.com
Background Routine infant immunisation with seven-valent pneumococcal conjugate vaccine
(PCV7) began in the USA in 2000. Although invasive pneumococcal disease has declined …

On the use of zero-inflated and hurdle models for modeling vaccine adverse event count data

CE Rose, SW Martin, KA Wannemuehler… - Journal of …, 2006 - Taylor & Francis
We compared several modeling strategies for vaccine adverse event count data in which the
data are characterized by excess zeroes and heteroskedasticity. Count data are routinely …

Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010

…, J Talarico, NE Messonnier, TA Clark, SW Martin - Jama, 2012 - jamanetwork.com
Context In 2010, California experienced its largest pertussis epidemic in more than 60 years;
a substantial burden of disease was noted in the 7- to 10-year-old age group despite high …

National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States

…, KA Poehling, JP Nuorti, Y Zhu, SW Martin… - …, 2006 - publications.aap.org
BACKGROUND. Since introduction of the heptavalent pneumococcal conjugate vaccine in
the United States in 2000, rates of invasive pneumococcal disease have declined. However, …

[HTML][HTML] Use of serogroup B meningococcal vaccines in persons aged≥ 10 years at increased risk for serogroup B meningococcal disease: recommendations of the …

T Folaranmi, L Rubin, SW Martin, M Patel… - … and Mortality Weekly …, 2015 - ncbi.nlm.nih.gov
Methods The ACIP Meningococcal Vaccines Work Group reviewed safety and immunogenicity
data from seven clinical trials of MenB-4C (2–7)(Novartis, unpublished data) and nine …

Pertactin-Negative Bordetella pertussis Strains: Evidence for a Possible Selective Advantage

SW Martin, L Pawloski, M Williams… - Clinical Infectious …, 2015 - academic.oup.com
An analysis assessing for associations between pertactin production and both clinical
presentation and vaccine history found a significant association between vaccination and pertactin …

Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity

…, TA Clark, L Misegades, SW Martin… - Clinical infectious …, 2013 - academic.oup.com
Background. The conjugate vaccine against serogroup A Neisseria meningitidis (NmA),
MenAfriVac, was first introduced in mass vaccination campaigns of 1–29-year-olds in Burkina …

Use of serogroup B meningococcal vaccines in adolescents and young adults: recommendations of the Advisory Committee on Immunization Practices, 2015

…, IR Ortega-Sanchez, M Patel, SW Martin - Morbidity and Mortality …, 2015 - JSTOR
Methods The ACIP Meningococcal Vaccines Work Group reviewed the immunogenicity and
safety data from seven clinical trials of MenB-FHbp (2–5)(Pfizer, unpublished data) and five …

Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine

KA Poehling, PG Szilagyi, CG Grijalva, SW Martin… - …, 2007 - publications.aap.org
OBJECTIVE. Streptococcus pneumoniae is an important cause of otitis media in children. In
this study we estimated the effect of routine childhood immunization with heptavalent …